DOCK2 and hepatocellular carcinoma: The frequent mutation of TP53, LRP1B, ARID1A, and DOCK2 in HCC has been confirmed in previous studies48–51, which was associated with poor survival, and our research also clarified this point (Fig. 5A, Fig. S5B).